Accessibility Menu
 
Numinus Wellness logo

Numinus Wellness

(TSX) NUMI

Current Price$0.05
Market Cap$16.03M
Since IPO (2020)-95%
5 Year-87%
1 Year-66%
1 Month+43%

Numinus Wellness Financials at a Glance

Market Cap

$16.03M

Revenue (TTM)

$4.47M

Net Income (TTM)

$14.60M

EPS (TTM)

$0.00

P/E Ratio

-0.52

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$0.05

Volume

989,752

Open

$0.04

Previous Close

$0.05

Daily Range

$0.04 - $0.05

52-Week Range

$0.04 - $0.05

NUMI News

No articles available.

NUMI: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Numinus Wellness

Industry

Pharmaceuticals

Employees

35

CEO

Michael Tan, MBA

Headquarters

Vancouver, BC V6B 1R4, CA

NUMI Financials

Key Financial Metrics (TTM)

Gross Margin

44%

Operating Margin

-63%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

-19%

Return on Assets

-3%

Earnings Yield

-1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$16.03M

Shares Outstanding

320.55M

Volume

989.75K

Short Interest

0.00%

Avg. Volume

0

Financials (TTM)

Gross Profit

$1.17M

Operating Income

$11.71M

EBITDA

$13.94M

Operating Cash Flow

$17.48M

Capital Expenditure

$25.48K

Free Cash Flow

$17.50M

Cash & ST Invst.

$1.96M

Total Debt

$2.03M

Numinus Wellness Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$1.80M

-58.5%

Gross Profit

$870.10K

-9.2%

Gross Margin

48.26%

N/A

Market Cap

$16.03M

N/A

Market Cap/Employee

$80.14K

N/A

Employees

200

N/A

Net Income

$711.18K

+87.6%

EBITDA

$517.89K

+88.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$1.50M

+55.5%

Accounts Receivable

$1.56M

-29.3%

Inventory

$0.00

N/A

Long Term Debt

$1.73M

-60.7%

Short Term Debt

$589.41K

-77.8%

Return on Assets

-2.58%

N/A

Return on Invested Capital

-18.76%

N/A

Free Cash Flow

$392.99K

+111.3%

Operating Cash Flow

$390.09K

+111.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATE.TOAntibe Therapeutics Inc.
$0.29+13.46%
REUN.TOReunion Neuroscience Inc.
$1.42-2.74%
EXM.CNEXMceuticals Inc.
$0.20+0.00%
IMCC.CNIM Cannabis Corp.
$5.10-40.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$5.87+2.79%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.07+0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.47-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.60+0.04%

Questions About NUMI

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.